Marxreiter F, Storch A, Winkler J
Abteilung für Molekulare Neurologie, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Deutschland.
Klinik und Poliklinik für Neurologie, Universität Rostock, Gehlsheimer Straße 20, 18147, Rostock, Deutschland.
Nervenarzt. 2016 Aug;87(8):805-13. doi: 10.1007/s00115-016-0157-2.
Parkinson's disease (PD) is the most common age-related movement disorder and characterized by slowly progressive neurodegeneration resulting in motor symptoms, such as bradykinesia, rigidity, tremor and postural instability. Moreover, non-motor symptoms, such as hyposmia, anxiety and depression reduce the quality of life in PD. Motor symptoms are associated with a distinct striatal dopaminergic deficit resulting from axonal dysfunction and neuronal loss in the substantia nigra (SN). Recent progress in stem cell technology allows the optimization of cellular transplantation strategies in order to alleviate the motor deficit, which potentially leads to a reactivation of this therapeutic strategy. Besides neurodegenerative processes impaired adult neurogenesis and consequentially reduced endogenous cellular plasticity may play an important role in PD. This article discusses the notion that non-motor symptoms in PD may partly be explained by reduced adult neurogenesis in the olfactory bulb and hippocampus.
帕金森病(PD)是最常见的与年龄相关的运动障碍,其特征是缓慢进行性神经退行性变,导致运动症状,如运动迟缓、僵硬、震颤和姿势不稳。此外,嗅觉减退、焦虑和抑郁等非运动症状会降低帕金森病患者的生活质量。运动症状与黑质(SN)轴突功能障碍和神经元丢失导致的纹状体多巴胺能明显缺乏有关。干细胞技术的最新进展使得细胞移植策略得以优化,以减轻运动功能障碍,这可能会使这种治疗策略重新受到关注。除了神经退行性过程,受损的成体神经发生以及随之降低的内源性细胞可塑性可能在帕金森病中起重要作用。本文讨论了帕金森病非运动症状可能部分由嗅球和海马体中成年神经发生减少所解释的观点。